Scottsdale, Arizona–(Newsfile Corp. – December 13, 2023) – Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the “Company”), announced the following:
Sibannac, Inc.’s Campus Co. (Campus Community) has agreed to principle terms with a major extraction partner to move its manufacturing operations and equipment into our Scottsdale facility. Upon full execution of the agreement, we will disclose the partner’s information and details regarding our clients and revenues. It is anticipated that Sibannac will generate annual top-line revenue approaching $1M in 2024.
Existing clients are large, nationally known supplement brands who will take our bulk oil extracts to finish into retail ready consumer goods. The new equipment includes HPLC (High Performance Liquid Chromatography), an analytical technique used to separate, identify or quantify each component in a mixture. The Company will be able to conduct onsite oil extraction and separate compounds like CBD, CBN, CBG, as well as Delta-8 and Delta-9 THC.
This relationship is expected to expand in 2024 into the manufacturing of non-cannabis consumer goods. Further disclosure and product details will follow upon full execution of the agreement. We have included photos of a sampling of the equipment herein, which has all been relocated and is being assembled at Sibannac’s facility at this time.
“This is a major coup for Sibannac, as we’re entering into the extraction space with one of the best partners in the industry. Make no mistake, the second generation companies that have survived in the cannabis space are going to thrive. Sibannac is getting in without any capital investment and, through our partner, we’re walking into a very stable and long-standing client base, that assures ongoing revenues,” said Sibannac’s Chief Executive Officer, David Mersky. “The future with our new partner, however, also heavily involves products in the non-cannabis, nutraceutical space, where their manufacturing tech is disruptive,” said Mersky.
Annual Report and Disclosure
The Company has filed its annual report for fiscal year 2023 which is now posted at OTC Markets.
The Kavern
The Kavern is the name of Sibannac’s first retail Kava/Kratom bar and is located in Scottsdale, Arizona. It will be open for the holiday season this year, as the buildout is nearly complete. Located near the heart of Scottsdale’s bustling, Old Town district, the Kavern will offer Kratom beverages, tinctures and capsules. It will also offer pre-packaged goods, including hemp-derived – legally compliant – Delta-9 THC gummies and beverages, our flagship Hangover remedy NOHO, unregulated mood-altering mushroom varieties – like Amanita Muscaria – as well as a line of natural supplements. Most of the inventory will be produced and packaged in our Scottsdale-based lab at Sibannac’s headquarters, just minutes from the Kavern.
After initial evaluation of the sales results and operations, the Company plans to open additional locations in Scottsdale and nearby Phoenix, creating a local hub to maximize production and operational efficiencies. Arizona is an ideal market to launch retail Kava/Kratom bars and lounges, given particularly beneficial age demographics in addition to enacting the Kratom Consumer Protection Act, which provides consumer confidence in the product’s safety, thereby encouraging new entrants to the consumer market.
About Sibannac
Sibannac, Inc. (OTC Pink: SNNC) is a Nevada corporation founded in 1999 and located in Scottsdale, Arizona. Sibannac currently specializes in creating and selling premium next generation wellness products in the consumer packaging goods space. In addition to mainstream supplements and its hangover shot, NOHO, the Company is producing Kratom and Hemp-derived Delta-8/9 products, and Amanita mushroom edibles for wholesale and retail sales and distribution. Sibannac provides contract manufacturing and white labeling services for independent firms and creates and manages its own brands from the concept phase through to distribution. Sibannac has opened its platform to outside clients to offer its marketing and brand-building assets, through its wholly owned subsidiaries, The Campus Co. and Immersive Brand Concepts.
More from Sibannac – For additional information and product updates, please follow us at The Campus Co. and follow us on Twitter at www.twitter.com/sibannacinc.
Media Contact: IR@theCampusCo.com
Extraction Equipment
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7785/190963_0d96a966848f68f8_002full.jpg
Cautionary Note Regarding Forward-Looking Statements.
This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Sibannac, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/190963
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…
Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…
SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…